csrxp_admin, Author at CSRxP - Page 42 of 90

CSRXP: ASTRAZENECA LEADS BIG PHARMA IN BRAZEN ASSAULT ON CRITICAL 340B PROGRAM, MUST BE HELD ACCOUNTABLE

Brand Name Drug Company Shirks Requirement to Provide Affordable Medications… Read More

CSRXP COMMENDS LAWMAKERS FOR REFOCUSING CRITICAL ATTENTION ON BIG PHARMA’S EGREGIOUS PRICE HIKES AND PRACTICES

House Committee on Oversight and Reform to Question Big Pharma Executives… Read More

DOSE OF REALITY: LAWMAKERS RIGHT TO TRAIN RENEWED FOCUS ON BIG PHARMA’S PRICE-GOUGING AND ANTI-COMPETITIVE TACTICS

Brand Name Drug Companies Must be Held Accountable for Pandemic Price Hikes… Read More

NEW STUDY: BIG PHARMA’S BIOLOGIC PATENT ABUSE WILL COST AMERICAN PATIENTS AN ADDITIONAL $25 BILLION WITHOUT REFORM

Report Finds Market-Based Solutions to Boost Biosimilar Competition and Hold… Read More

ICYMI: LA TIMES – VACCINE MAKER GOT $1 BILLION FROM TAXPAYERS. NOW IT’S BOOSTING DRUG PRICES

Brand Name Drug Maker AstraZeneca Aggressively Raised Prices In The Middle Of… Read More

ICYMI: STUDY SHOWS BIG PHARMA’S ANTI-COMPETITIVE GAMESMANSHIP COMES AT TREMENDOUS COST TO U.S. HEALTHCARE SYSTEM

Report Finds Just Five Instances Of Product Hopping Sticks Americans With $4.7… Read More

CSRXP: PRESIDENT SHOULD FOCUS ON HOLDING BIG PHARMA ACCOUNTABLE TO LOWER RX PRICES, ABANDON REBATE RULE

Tweet Misstates Impact of Misguided Rebate Rule That Would Do Nothing to Lower… Read More

ICYMI: REPORT CONFIRMS REBATE RULE WOULD HIKE PREMIUMS, COST TAXPAYERS BILLIONS OF DOLLARS AND BOOST “DRUG COMPANY REVENUES”

Study Finds Rebates Negotiated By PBMs Reduce Rx Costs and Lower Premiums –… Read More

CSRxP Commends Congressional Probe Of Big Pharma Giant’s Anti-Competitive Tactics and Egregious Pricing Practices

U.S. House Oversight Committee Subpoena of AbbVie Related to Pricing of… Read More

ICYMI: STAT NEWS – NEW POLL SHOWS WIDE SUPPORT FOR SEVERAL TRUMP DRUG PRICING REFORMS, BUT NOT REBATE CHANGES

Administration Should Shelve Rebate Rule That Would Increase Medicare… Read More

BIG PHARMA DOUBLES DOWN ON SUMMER PRICE HIKES AS AMERICANS CONTINUE TO BATTLE PANDEMIC

Tracking Data Finds Drug Companies Increased Prices On at Least 67 Brand Name… Read More

CSRXP: BIG PHARMA’S COUNTEROFFER TO WHITE HOUSE WOULD HURT AMERICAN SENIORS & DO NOTHING TO LOWER DRUG PRICES

White House Should Reject Pharma-Backed Policies That Would Hand Drug… Read More